Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HBW Insight is a single source of regulatory, legislative, legal and commercial news and insight connecting the dots across 3 sectors, including over the counter medicines, vitamins and dietary supplements, and cosmetics, which have increasing points of intersection, helping you to anticipate global challenges, risks, and opportunities.
How it helps
HBW Insight gives you the power to go behind the news stories to understand the implications of worldwide industry developments across three different but complementary consumer healthcare sectors, on your business.
How it works
A broad network of global expert analysts and journalists give you an insider’s perspective from tracking market events and their impacts from around the globe, to understand the potential impact of developments and trends. Plus, access to exclusive interviews with key opinion leaders and market movers. We also draw on the strength and expertise of the rest of the Pharma Intelligence family of analytical and market intelligence tools.
Health:
In-depth coverage and analysis of:
Beauty:
News and emerging issues in this rapidly evolving global sector on:
Wellness:
Up-to-the-minute news and the informed perspective on:
HBW Insight
Coronavirus pandemic drove up sales of vitamin C supplements and other immunity boosters in Italy in the opening three months of the year.
HBW Insight
UK's NICE reviews whether Vitamin D can prevent or treat COVID-19, finds evidence wanting.
HBW Insight
Reckitt Benckiser's TV ad for Nurofen in New Zealand drew numerous complaints for being "socially irresponsible" during the COVID-19 pandemic.
HBW Insight
Assertions that no convincing evidence supports that probiotics available in the US treat symptoms of diarrhea, irritable bowel syndrome or allergies look at the category as a whole and not individual strains shown to help with specific conditions, say consumer health industry groups.
Topic Coronavirus Dietary Supplements Research & Development
HBW Insight
The COVID-19 pandemic has impacted the consumer health and beauty products industries in different ways, and HBW Insight covers it all. We deliver all the latest regulatory, legislative, legal and commercial developments across the over-the-counter medicine, dietary supplement and the cosmetics sectors to keep you informed and strategically on target.
Topic Coronavirus
HBW Insight
FDA and FTC continue adding to total each has made during novel coronavirus pandemic. FTC's latest include peroxide gel and licorice as treatments; FDA’s emphasizes in warnings that three businesses' tests were not approved for OTC sales or for home use.
HBW Insight
While stockpiling for immune health support drove early sales growth in response to the pandemic, probiotic sales likely will continue increasing, says DuPont Nutrition probiotic marketing head Vanessa Bailey. “My gut tells me I think we could see some sustained increase. There’s going to be some difference in how we behave.”
Topic Coronavirus
HBW Insight
Charlotte’s Web is strengthening its DTC lead while growing its brick-and-mortar retail business, accelerating its pet product distribution and working to close its Abacus Health acquisition announced in March. The Boulder, CO-based CBD product manufacturer posted a 1% decline in net sales for the first quarter, but expects a rapid escalation in the second half of the year.
Topic Coronavirus
HBW Insight
FTC nearly doubles its total of warnings on false and misleading COVID-19 claims for consumer health products with 50 announced on 21 May. WHO reported the same day that the largest number of COVID-19 cases, more than 106,000, were recorded in any 24-hour period during the pandemic.
Topic Coronavirus
HBW Insight
Researchers say “no strong” evidence shows high vitamin D intake is beneficial to preventing or treating COVID-19, but adequate levels are needed to support immunity. Other researchers say countries should increase recommended vitamin D levels with “very suggestive” evidence supporting its effect against COVID-19 severity.
Topic Coronavirus
HBW Insight
Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend.
HBW Insight
IFRA’s new chairman Hans Holger Gliewe says one possible positive outcome of the COVID-19 pandemic could be that consumers go on putting a premium on scientific expertise after months of reliance on health experts’ advice.
Topic Coronavirus Cosmetics
HBW Insight
Bayer posts double-digit rise in Q1 Consumer Health sales off the back of unprecedented demand for its dietary supplements in the middle of the global coronavrius pandemic.
Topic Coronavirus
HBW Insight
Review by MHRA advisory body finds no issue with ibuprofen use in COVID-19 patients and updates advice to recommend either paracetamol or ibuprofen to treat symptoms.
Topic Coronavirus
HBW Insight
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
Topic Coronavirus
HBW Insight
03 Aug 2020
HBW Insight
03 Aug 2020
HBW Insight
03 Aug 2020
HBW Insight
03 Aug 2020
HBW Insight
01 Aug 2020
HBW Insight
31 Jul 2020
HBW Insight
31 Jul 2020
HBW Insight
31 Jul 2020
HBW Insight
31 Jul 2020
HBW Insight
31 Jul 2020
HBW Insight
30 Jul 2020
HBW Insight
30 Jul 2020
HBW Insight
30 Jul 2020
HBW Insight
30 Jul 2020
HBW Insight
30 Jul 2020
UK
Richard specializes in
+27 year(s) experience
Washington DC, USA
Eileen specializes in
+20 year(s) experience
USA
Ryan specializes in
+16 year(s) experience
Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries. With catalyst tracking and expert insights, Biomedtracker helps you stay on top of breaking events, the drugs pipeline, upcoming milestones, companies, and deals – and their impact on the markets you care about.
Understand what’s happening in the market right now and what it means for the future of your business with news and insight from our team of journalists and analysts. Scrip is essential for anyone making commercial decisions in the pharmaceutical industry.
Biomedtracker, Strategic Transactions, and Medtrack have been combined into a single commercial intelligence solution, enabling you to make the most informed decisions to develop successful commercial strategies. Track and understand the impacts of market events for the companies, diseases, products, and targets you care about.
Looking for more products Product Finder
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
